Editor Profile

Michael R. McClung, MD, FACP, FACE

Contributing Editor

About the NEJM Journal Watch Women’s Health Board

Michael R. McClung, MD, FACP, FACE, is the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Dr. McClung was a member of the WHO Fracture Risk Task Force that led to the development of the FRAX tool. He has served on the FDA’s Endocrinology and Metabolism Advisory Committee and participated in the development of evidence-based guidelines for the treatment of osteoporosis for several national and international societies. He has been writing for NEJM Journal Watch Women's Health since 2016.


Consultant / Advisory board

Amgen; Merck; Radius

Editorial boards

BoneKey; Menopause; Osteoporosis International

Summaries by Michael McClung